---
figid: PMC7527574__gr1
figlink: pmc/articles/PMC7527574/figure/f0005/
number: Fig. 1
caption: Therapeutic targeting of HGF/c-Met pathway. c-Met pathway inhibition can
  be achieved using c-Met tyrosine kinase inhibitors, like cabozantinib, tivantinib,
  and TAS-115 (black boxes), through inhibition of several signalling pathways responsible
  for promoting proliferation, migration, invasion, and metastases formation. AKT
  serine/threonine-protein kinase, AXL AXL receptor tyrosine kinase, BAD BCL2 associated
  agonist of cell death, ERK extracellular signal-regulated kinase, MEK mitogen-activated
  protein kinase kinase , mTOR mammalian target of rapamycin, NF-κB nuclear factor
  kappa B, p38 p38 mitogen-activated protein kinase, PI3K phosphoinositide 3-kinase,
  RAS rat sarcoma virus homolog, RAF RAF serine/threonine-protein kinase, SRC proto-oncogene
  tyrosine-protein kinase, STAT signal transducer and activator of transcription,
  VEGF vascular endothelial growth factor, VEGFR vascular endothelial growth factor
  receptor.
pmcid: PMC7527574
papertitle: c-Met expression in renal cell carcinoma with bone metastases.
reftext: Rita Silva Paiva, et al. J Bone Oncol. 2020 Dec;25:100315.
pmc_ranked_result_index: '56270'
pathway_score: 0.9669915
filename: gr1.jpg
figtitle: Therapeutic targeting of HGF/c-Met pathway
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7527574__gr1.html
  '@type': Dataset
  description: Therapeutic targeting of HGF/c-Met pathway. c-Met pathway inhibition
    can be achieved using c-Met tyrosine kinase inhibitors, like cabozantinib, tivantinib,
    and TAS-115 (black boxes), through inhibition of several signalling pathways responsible
    for promoting proliferation, migration, invasion, and metastases formation. AKT
    serine/threonine-protein kinase, AXL AXL receptor tyrosine kinase, BAD BCL2 associated
    agonist of cell death, ERK extracellular signal-regulated kinase, MEK mitogen-activated
    protein kinase kinase , mTOR mammalian target of rapamycin, NF-κB nuclear factor
    kappa B, p38 p38 mitogen-activated protein kinase, PI3K phosphoinositide 3-kinase,
    RAS rat sarcoma virus homolog, RAF RAF serine/threonine-protein kinase, SRC proto-oncogene
    tyrosine-protein kinase, STAT signal transducer and activator of transcription,
    VEGF vascular endothelial growth factor, VEGFR vascular endothelial growth factor
    receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - FLT1
  - FLT4
  - KDR
  - AXL
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - SRC
  - HRAS
  - KRAS
  - NRAS
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - AKT2
  - AKT3
  - AKT1
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - BAD
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - Tivantinib
  - Carbozantinib
genes:
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: AXL
  symbol: AXL
  source: hgnc_symbol
  hgnc_symbol: AXL
  entrez: '558'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Tivantinib
  source: MESH
  identifier: C551661
- word: Carbozantinib
  source: ''
  identifier: ''
diseases: []
---
